PharmaCielo Ltd. (PCLOF)
PharmaCielo Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.03, down 11.43% on the session, giving a market capitalisation of $6.2M. On trailing twelve-month figures it carries a trailing P/E of -1.87, a net margin of -103.1%. Its beta of 1.06 implies it has historically moved more than the broad market.
PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medicinal products. Additionally, the company diversifies its offerings by providing telemedicine software. Its clientele spans a range of entities, such as health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies, across both Canada and Colombia. PharmaCielo also holds a strategic partnership with AssuredTrans Inc., and its corporate headquarters are situated in Toronto, Canada.
PharmaCielo Ltd. is most often compared with the following Healthcare names: